Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 2
1987 1
1988 3
1989 6
1990 6
1991 11
1992 10
1993 27
1994 26
1995 37
1996 31
1997 44
1998 50
1999 47
2000 66
2001 71
2002 63
2003 80
2004 100
2005 120
2006 127
2007 159
2008 197
2009 226
2010 280
2011 363
2012 365
2013 471
2014 608
2015 652
2016 685
2017 794
2018 999
2019 1089
2020 1262
2021 1496
2022 1782
2023 1825
2024 1809
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,381 results

Results by year

Filters applied: . Clear all
Page 1
MAVS integrates glucose metabolism and RIG-I-like receptor signaling.
He QQ, Huang Y, Nie L, Ren S, Xu G, Deng F, Cheng Z, Zuo Q, Zhang L, Cai H, Wang Q, Wang F, Ren H, Yan H, Xu K, Zhou L, Lu M, Lu Z, Zhu Y, Liu S. He QQ, et al. Among authors: lu z. Nat Commun. 2023 Sep 2;14(1):5343. doi: 10.1038/s41467-023-41028-9. Nat Commun. 2023. PMID: 37660168 Free PMC article.
A snoRNA-tRNA modification network governs codon-biased cellular states.
Zhang M, Li K, Bai J, Van Damme R, Zhang W, Alba M, Stiles BL, Chen JF, Lu Z. Zhang M, et al. Among authors: lu z. Proc Natl Acad Sci U S A. 2023 Oct 10;120(41):e2312126120. doi: 10.1073/pnas.2312126120. Epub 2023 Oct 4. Proc Natl Acad Sci U S A. 2023. PMID: 37792516 Free PMC article.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: lu z. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
Genetic Control of Alternative Splicing and its Distinct Role in Colorectal Cancer Mechanisms.
Zhang M, Chen C, Lu Z, Cai Y, Li Y, Zhang F, Liu Y, Chen S, Zhang H, Yang S, Gen H, Jiang Y, Ning C, Huang J, Wang W, Fan L, Zhang Y, Jin M, Han J, Xiong Z, Cai M, Liu J, Huang C, Yang X, Xu B, Li H, Li B, Zhu X, Wei Y, Zhu Y, Tian J, Miao X. Zhang M, et al. Among authors: lu z. Gastroenterology. 2023 Nov;165(5):1151-1167. doi: 10.1053/j.gastro.2023.07.019. Epub 2023 Aug 3. Gastroenterology. 2023. PMID: 37541527
14,381 results
You have reached the last available page of results. Please see the User Guide for more information.